Chintan Dave, a core faculty member of the Center for Pharmacoepidemiology and Treatment Science at Rutgers Institute for Health, Health Care Policy and Aging Research, told Newsweek that patients should not stop or reconsider GLP-1 medications solely because of this potential risk
Beyond the prescription: Global observations on the social implications of GLP-1 receptor agonists for weight loss
Access varies by program
Examining the diverse landscape of vitamin injections, exploring the benefits, potential drawbacks, and alternative approaches in the pursuit of overall health and wellness
For the right patient, microdosing a compounded GLP-1 medication (tirzepatide + methylated B12) can be a gentle, effective way to calm your body, improve digestion, and stabilize energy all while supporting hormones, metabolism, and the nervous system
Andrews CN, et al